Paediatric Active Enhanced Disease Surveillance (PAEDS) 2019: Prospective hospital-based surveillance for serious

Nicole Dinsmore1, Jocelynne E McRae1,2, Helen E Quinn3,4

  • 1National Centre for Immunisation Research and Surveillance (NCIRS), Kids Research Institute, The Children's Hospital at Westmead.

Insights

The Paediatric Active Enhanced Disease Surveillance (PAEDS) network monitored serious childhood illnesses in Australia during 2019. It tracked vaccine-preventable diseases and adverse events, providing crucial data for public health.

Area of Science:

  • Paediatric infectious diseases
  • Public health surveillance
  • Immunisation safety

Background:

  • The Paediatric Active Enhanced Disease Surveillance (PAEDS) network is an Australian hospital-based system for monitoring serious childhood conditions.
  • It focuses on vaccine-preventable diseases and potential adverse events following immunisation (AEFI).
  • This report details surveillance data collected in 2019.

Purpose of the Study:

  • To present surveillance data for serious paediatric conditions in Australia for 2019.
  • To monitor vaccine-preventable diseases and potential adverse events following immunisation.
  • To inform public health policy and interventions.

Main Methods:

  • Utilised a hospital-based active surveillance system across seven Australian paediatric tertiary referral hospitals.
  • Specialist nurses prospectively identified and recorded cases daily using standardised protocols and case definitions.
  • Conditions monitored included acute flaccid paralysis, encephalitis, influenza, intussusception, pertussis, varicella-zoster virus, invasive meningococcal disease, invasive Group A streptococcus, Kawasaki disease, and gram-negative bloodstream infections.

Main Results:

  • Captured 2,701 cases across all monitored conditions in 2019.
  • Demonstrated high influenza activity and identified influenza-associated deaths in encephalitis cases.
  • Reported a reduction in varicella and invasive meningococcal disease cases, with serotype B predominating.
  • Initiated monitoring for Kawasaki disease and gram-negative bloodstream infections.

Conclusions:

  • PAEDS provides essential, policy-relevant data on serious paediatric conditions through enhanced sentinel surveillance.
  • The system contributes to national surveillance efforts, including WHO reporting targets for poliomyelitis.
  • Findings support public health strategies related to vaccination and disease control in children.
Abstract

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
248
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.2K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
37
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
525